Common Equity And Earnings Per Share Data	9 Months Ended
Sep. 30, 2024
Common Equity And Earnings Per Share Data [Abstract]
Common Equity And Earnings Per Share Data	4. COMMON EQUITY AND EARNINGS PER SHARE DATA The common stock per share information is based upon the weighted average number of shares outstanding during each period. For the three and nine month periods ended September 30, 2024 the Company had an average of 15,351 and 11,389 dilutive shares outstanding, respectively. For the three and nine month periods ended September 30, 2023 the company had an average of 9,034 and 16,773 diluted shares outstanding, respectively. Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive and not included in calculating diluted earnings per share. For the three and nine month periods ended September 30, 2024, there was an average of 77,550 and 77,807 potentially anti-dilutive shares outstanding, respectively. Potentially anti-dilutive shares outstanding were not included in calculating diluted earnings per share because their effect was anti-dilutive.

Common Equity And Earnings Per Share Data

9 Months Ended

Sep. 30, 2024

Common Equity And Earnings Per Share Data [Abstract]

Common Equity And Earnings Per Share Data

4. COMMON EQUITY AND EARNINGS PER SHARE DATA

The common stock per share information is based upon the weighted average number of shares outstanding during each period. For the three and nine month periods ended September 30, 2024 the Company had an average of 15,351 and 11,389 dilutive shares outstanding, respectively. For the three and nine month periods ended September 30, 2023 the company had an average of 9,034 and 16,773 diluted shares outstanding, respectively.

Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive and not included in calculating diluted earnings per share. For the three and nine month periods ended September 30, 2024, there was an average of 77,550 and 77,807 potentially anti-dilutive shares outstanding, respectively. Potentially anti-dilutive shares outstanding were not included in calculating diluted earnings per share because their effect was anti-dilutive.

EVANS BANCORP INC 10-Q